Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis
IntroductionBladder cancer (BC) is a significant carcinoma of the urinary system that has a high incidence of morbidity and death owing to the challenges in accurately identifying people with early-stage BC and the lack of effective treatment options for those with advanced BC. Thus, there is a need...
Main Authors: | Weifeng Wang, Guankai Huang, Hansen Lin, Lei Ren, Liangmin Fu, Xiaopeng Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1102392/full |
Similar Items
-
Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis
by: Weifeng Wang, et al.
Published: (2024-01-01) -
Prognostic value of CLIC3 mRNA overexpression in bladder cancer
by: Mei Chen, et al.
Published: (2020-01-01) -
High Usability and Applicability Ratings for the New SmartClic®/ClicWise® Injection Device: Evidence from a Health Care Professional Opinion Study
by: Rieke Alten, et al.
Published: (2023-01-01) -
Transmembrane Chloride Intracellular Channel 1 (tmCLIC1) as a Potential Biomarker for Personalized Medicine
by: Francesca Cianci, et al.
Published: (2021-07-01) -
Proteome dataset of Hemileia vastatrix by LC–MS/MS label-free identification
by: Natália Faustino Cury, et al.
Published: (2022-08-01)